You have 9 free searches left this month | for more free features.

Condition

Advanced Breast Cancer (1)

Advanced or Metastatic Breast Cancer (1)

Breast Cancer (1)

Metastatic Breast Cancer (1)

Metastatic Colorectal Cancer (1)

Overall Status

Active, not recruiting (1)

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Menarini Group (2)

MedSIR (1)

Collaborator

Menarini Group (1)

Intervention

men1611 (3)

cetuximab (1)

eribulin (1)

fulvestrant (1)

trastuzumab (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (3)

men1611

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial (MEN1611, Eribulin)

Not yet recruiting

Breast Cancer
+2 more

MEN1611
Eribulin

(no location specified)

Apr 12, 2023

Metastatic Colorectal Cancer Trial in Worldwide (MEN1611, Cetuximab)

Recruiting

Metastatic Colorectal Cancer

MEN1611
Cetuximab

Phoenix, Arizona
+26 more

Feb 14, 2022

Advanced or Metastatic Breast Cancer Trial in Worldwide (MEN1611, Trastuzumab, Fulvestrant)

Active, not recruiting

Advanced or Metastatic Breast Cancer

MEN1611
+2 more

Fort Lauderdale, Florida
+26 more

Feb 14, 2022